Infertility Treatment Market by Product (Equipment, Media, Accessories), Procedure (ART (IVF,ICSI, Surrogate), Insemination, Laparoscopy, Hysteroscopy, Patient Type (Female, Male), End User (Fertility Clinics, Hospitals, Research)- Global Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2022-2030
The global Infertility Treatment market size was estimated at USD 1.20 billion in 2021 and is expected to surpass around USD 6.2 billion by 2030 and poised to grow at a compound annual growth rate (CAGR) of 12.4% during the forecast period 2022 to 2030.
Infertility can be defined as the inability of an individual to reproduce by natural means. The causes of infertility are extremely diverse. It can be due to advancement of maternal age, disorders in the occurrence of ovulation, tubal occlusion or blockage, genetics, sexually transmitted infections, immune infertility, endometrial polyps, uterine fibroids, infertility due to male factors, endometriosis, and others. According to CDC, in the U.S., 1 in every 8 couples or approximately 12% of married women face complications to attain pregnancy. Around one third infertility cases are due to the female partner, another one third due to the male counterpart, and the remaining are attributed to both the partners or other unexplained infertility causes. Fertility rate has halved since 1960. Treatment options for infertility include education or spreading awareness, medications to assist the development of egg during the ovulation period, insemination, in vitro fertilization (IVF), and third party reproduction surgery.
Increase in the number of cases of infertility can be attributed to rise in physical inactivity, continual shift toward sedentary lifestyle, improper fetal care, delayed pregnancy, smoking, excessive consumption of alcohol, stress, and others. Moreover, rise in prevalence of diabetes and obesity is the key factor contributing to the increase in rate of these conditions. Surge in the number of fertility clinics across the world coupled with advancement in technologies to treat infertility among both men and women drives the global infertility treatment market. Furthermore, increase in investments by the public and private sectors in the health care industry has led to a conducive environment for the growth of the global infertility treatment market. However, high cost of procedures associated with reproductive techniques and other factors such as decreased efficacy among elderly women are likely to be major restraints of the global infertility treatment market in the next few years.
Report Scope of the Infertility Treatment Market
US$ 6.2 Billion by 2030
CAGR of 12.4% from 2022 to 2030
Fastest Growing Market
2022 to 2030
Product, Procedure, Patient Type, End user and Region,
The Cooper Companies Inc. (US), Cook Group (US), Vitrolife (Sweden), Thermo Fisher Scientific, Inc. (US), Esco Micro Pte. Ltd. (Singapore), Genea Biomedx (Australia), IVFtech ApS (Denmark), FUJIFILM Irvine Scientific (US), The Baker Company, Inc. (US), Kitazato Corporation (Japan), Rocket Medical plc (UK), IHMedical A/S (Denmark), Hamilton Thorne Ltd. (US), ZEISS Group (Germany), MedGyn Products, Inc. (US), DxNow, Inc. (US), Nidacon International AB (Sweden), Gynotec B.V. (Netherlands), SAR Healthline Pvt. Ltd. (India), and InVitroCare Inc. (US)
Infertility treatment Market Dynamics
Driver: Declining fertility rate
The fertility rate worldwide is declining steadily owing to various factors, such as the growing trend of late marriages and increasing age-related infertility. Global fertility rates are projected to decline to 2.4 children per woman by 2030 and 2.2 children per woman by 2050. This declining fertility rate has led to a significant increase in the demand for infertility treatment products that determine the fertility window in males and females
Restraint: High costs associated with assisted reproductive technology in developed markets
Along with fertility surgeries, thousands of cycles of ART procedures such as in vitro fertilization (IVF) are performed every year globally. The cost of IVF treatment varies from country to country due to the lack of reimbursement policies. A lack of insurance coverage and the poor reimbursement scenario in some parts of the world are limiting the growth of this market.
Opportunity: Emerging markets in APAC and RoW
Emerging markets such as China, India, Brazil, and Mexico are expected to offer significant growth opportunities for players in the infertility treatment market. The infertility treatment market in Asia and other emerging countries is characterized by the growing focus on healthcare infrastructural improvements. Additionally, the medical tourism industry in emerging countries is thriving owing to a number of factors. In Asia, healthcare facilities are of high quality, treatment procedures are affordable, and many of the doctors and surgeons are trained and educated in the top institutes in the US and Europe. Emerging countries such as India, China, Singapore, Thailand, Brazil, and Malaysia present significant opportunities for the growth of the infertility treatment market.
To leverage the significant growth opportunities in emerging countries, players are increasingly focusing on undertaking strategic developments agreements/partnerships with regional/domestic players, geographical expansions, and acquisitions.to increase their presence in these markets and tap a large number of customers. In addition, government \initiatives to increase the accessibility of infertility treatments, and the growing number of fertility centers are also fuelling the growth of infertility treatment procedures in emerging countries.
Challenge: Concerns related to ART procedures
Assisted reproductive technology (ART) involves procedures that require the handling of the human egg and embryos. Since the inception of ART procedures, there have been various ethical, legal, and societal controversies regarding the safe administration of gonadotropins, transparency of pregnancy data from clinics, and addressing economic barriers to ART access. Issues related to embryos and what to do with unused embryos are one of the major concerns related to the ART procedure.
In order to monitor activities related to ART procedures, strict regulations have been formulated by authorities in various countries across the globe. Authorities such as the International Federation of Fertility Societies (IFFS), European Society of Human Reproduction and Embryology (ESHRE), Indian Council of Medical Research (ICMR), Ethics Committee of American Society for Reproductive Medicine (ASRM), and Human Fertilization and Embryology Authority (HFEA) have implemented stringent regulations for infertility treatment.
These ethical concerns and restrictions on ART procedures, however, limit the adoption of infertility treatments to a certain extent
The equipment to capture the largest share in infertility treatment market, by products during the forecast period.
The equipment segment is expected to witness the highest growth rate during the forecast period. The high growth in this owes to the technological advancements and presence of well-established players with strong product portfolio. Along with this growing focus of players towards base expansion through adopting various strategies such as new equipment launch, showcase across the globe is likely to contribute towards the growth of the segment.
The assisted reproductive technology (ART) to capture the largest market share of infertility treatment market, by procedure in 2021.”
The assisted reproductive technology segment captured the largest share of the infertility treatment market procedures during the forecast period. The growing awareness of the presence of ART, rise in success rate of this procedure and growing worldwide acceptance of ART is likely to boost the growth of the segment.
The female infertility treatment segment commanded for the largest share of the infertility treatment market, by patient type, in 2021
The decreasing rates of fertility among females, the growing availability of various fertility treatment options, and the increasing number of fertility centers across the globe are driving the growth of the female infertility treatment market.
The fertility centers segment accounted for the largest share of the infertility treatment market, by end user, in 2021
The rising government initiatives to establish fertility clinics, initiatives taken by large international healthcare providers to establish fertility centers, and the increasing popularity of IVF & ICSI treatment globally are some of the factors likely to contribute towards the rapid growth of the segment.
Asia Pacific is the largest regional market for infertility treatment market
Asia Pacific dominates the infertility treatment market. Significant rise in the medical tourism, Increase in the awareness of availability of infertility treatment procedures, growing fertility centers in the region, rising healthcare expenditures, increasing rate of infertility in the region, and initiatives by the government to increase the accessibility of the infertility treatment in the emerging nations.
Some of the prominent players in the Infertility Treatment Market include:
The Cooper Companies Inc. (US), Cook Group (US), Vitrolife (Sweden), Thermo Fisher Scientific, Inc. (US), Esco Micro Pte. Ltd. (Singapore), Genea Biomedx (Australia), IVFtech ApS (Denmark), FUJIFILM Irvine Scientific (US), The Baker Company, Inc. (US), Kitazato Corporation (Japan), Rocket Medical plc (UK), IHMedical A/S (Denmark), Hamilton Thorne Ltd. (US), ZEISS Group (Germany), MedGyn Products, Inc. (US).
Segments Covered in the Report
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For this study, Nova one advisor, Inc. has segmented the global Infertility Treatment market
- Imaging Systems
- Sperm Analyzer Systems
- Ovum Aspiration Pumps
- Micromanipulator Systems
- Gas Analyzers
- Laser Systems
- Sperm Separation Devices
- Media & Consumables
- Assisted Reproductive Technology
- In Vitro Fertilization
- Intracytoplasmic Morphologically Selected Sperm Injection
- Gamete Donation
- Intracytoplasmic Sperm Injection
- Artificial Insemination
- Intrauterine Insemination
- Intracervical Insemination
- Intratubal Insemination
- Fertility Surgeries
- Tubal Ligation Reversal
- Microsurgical Reconstruction
- Other Infertility Treatment Procedures
By Patient type
- Female Infertility Treatment
- Male Infertility Treatment
By End User
- Fertility Centers
- Hospitals & Surgical Clinics
- Research Institutes
- United Kingdom
- Rest of Europe
- Southeast Asia
- Rest of Asia Pacific
- Rest of Latin America
Middle East & Africa (MEA)
- North Africa
- South Africa
- Rest of Middle East & Africa
Key Benefits for Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the global Infertility Treatment industry analysis from 2022 to 2030 to identify the prevailing Infertility Treatment industry opportunity.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the global Infertility Treatment industry segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global Infertility Treatment industry trends, key players, market segments, application areas, and market growth strategies.